Saturday 17 October 2026
Export ALC’s income statement to Excel — free account
Alcon
ALC Healthcare Medical Instruments & Supplies
Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024. In the quarter to June 2026, revenue grew 8.74%, EPS fell 100.0%, free cash flow was flat and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
66.18
0.40
−0.60%
Follow ALC
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | 4 | 7 | 4 | 7 | 8 | 6 |
P/E ratio |
0.00 | 21.68 | 0.00 | 0.00 | 0.00 | 114.02 | 101.44 | 39.11 | 41.41 | 39.60 |
P/S ratio |
0.00 | 0.00 | 0.00 | 3.68 | 4.72 | 5.15 | 3.89 | 4.02 | 4.23 | 3.74 |
Altman Z″-Score (non-manufacturers) |
8.16 | — | — | — | — | — | — | — | — | — |
P/FCF ratio |
0.00 | 0.00 | 51.80 | 113.19 | 123.15 | 258.72 | 71.82 | 70.73 | 29.83 | 24.10 |
Beneish M-Score |
— | — | — | (3.28) | (2.72) | (2.64) | (2.50) | (2.49) | (2.65) | (2.56) |
P/Operating CF |
944.50 | 944.50 | 944.50 | 79.82 | 73.49 | 110.31 | 98.25 | 84.21 | 91.44 | 59.07 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 66 |
P/B ratio |
1.25 | 1.25 | 1.25 | 1.43 | 1.71 | 2.22 | 1.72 | 1.84 | 1.95 | 1.76 |
Price to Tangible BV |
1.25 | 1.25 | 1.25 | 165.37 | 39.35 | 26.92 | 31.92 | 14.40 | 10.44 | 10.30 |
EV/Sales |
0.00 | 0.00 | 0.00 | 4.03 | 5.10 | 5.45 | 4.31 | 4.40 | 4.52 | 4.04 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 23.86 | 30.44 | 25.11 | 21.07 | 18.38 | 16.97 | 16.46 |
EV/Operating CF |
24.14 | 24.14 | 24.14 | 32.91 | 42.32 | 33.60 | 30.87 | 29.99 | 21.56 | 18.49 |
EV/FCF |
51.63 | 51.63 | 51.63 | 124.08 | 132.92 | 273.90 | 79.59 | 77.52 | 31.83 | 26.04 |
Quick Ratio |
1.00 | 1.03 | 0.81 | 0.97 | 1.30 | 1.25 | 0.97 | 1.21 | 1.58 | 1.17 |
Current Ratio |
1.81 | 1.85 | 1.80 | 1.84 | 2.21 | 2.18 | 1.90 | 2.35 | 2.77 | 2.12 |
Net Debt/EBITDA |
0.07 | (0.02) | (0.07) | 2.09 | 2.24 | 1.39 | 2.06 | 1.61 | 1.07 | 1.23 |
Debt/Assets |
0.90% | 0.00% | 0.51% | 12.58% | 14.92% | 14.57% | 15.94% | 16.00% | 15.30% | 15.01% |
Debt/Equity |
0.01 | 0.01 | 0.01 | 0.18 | 0.22 | 0.21 | 0.24 | 0.23 | 0.22 | 0.22 |
Asset Turnover |
0.23 | 0.49 | 0.26 | 0.27 | 0.25 | 0.30 | 0.31 | 0.32 | 0.33 | 0.34 |
Operating CF/Net income |
(7.35) | 4.76 | (5.02) | (1.40) | (1.55) | 3.58 | 3.63 | 1.43 | 2.04 | 2.32 |
Capex/Depreciation |
0.00 | 0.00 | (0.44) | (0.46) | (0.34) | (0.97) | (0.67) | (0.69) | (0.55) | (0.55) |
Interest Coverage |
0.63 | (5.63) | (10.33) | (1.65) | (3.89) | 4.83 | 5.01 | 5.50 | 7.36 | 6.67 |
| (0.71%) | 1.12% | (1.00%) | (3.13%) | (2.79%) | 1.97% | 1.72% | 4.83% | 4.83% | 4.50% | |
| (0.60%) | 1.86% | (0.83%) | (2.40%) | (1.92%) | 1.35% | 1.17% | 3.31% | 3.40% | 3.17% | |
ROIC |
0.00% | 0.00% | (0.69%) | (0.53%) | (1.41%) | 1.67% | 1.80% | 2.68% | 3.62% | 3.38% |
Return on Tangible Assets |
(4.51%) | 6.36% | (5.27%) | (12.99%) | (8.63%) | 5.68% | 5.17% | 12.79% | 12.09% | 11.99% |
Average Days of Receivables |
85.60 | 88.56 | 66.64 | 68.40 | 73.82 | 66.26 | 70.60 | 69.64 | 64.78 | 68.85 |
Research and Development Expense of Revenue |
7.57% | 8.60% | 8.21% | 8.74% | 9.85% | 10.16% | 8.05% | 8.76% | 8.84% | 9.52% |
Selling, General and Administrative Expense of Revenue |
38.30% | 38.22% | 39.16% | 37.92% | 39.43% | 37.10% | 35.20% | 33.94% | 32.79% | 33.16% |
Intangible Assets out of Total Assets |
0.77 | 0.00 | 0.72 | 0.69 | 0.65 | 0.63 | 0.64 | 0.61 | 0.58 | 0.58 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 1.11% | 1.54% | 1.66% | 1.61% | 1.52% | 1.51% | 1.56% |
Graham Net Nets |
0.12 | 0.12 | 0.12 | (0.15) | (0.12) | (0.08) | (0.13) | (0.09) | (0.06) | (0.08) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 25.99 | 24.75 | 43.06 | 44.84 | 44.73 |
Earnings Yield |
(6.67%) | 4.61% | (0.44%) | (2.39%) | (1.65%) | 0.88% | 0.99% | 2.56% | 2.41% | 2.53% |
Free Cash Flow Yield |
0.00% | 0.00% | 1.93% | 0.88% | 0.81% | 0.39% | 1.39% | 1.41% | 3.35% | 4.15% |
Revenue per Share |
0.00 | 13.95 | 14.65 | 15.38 | 13.97 | 16.92 | 17.74 | 19.18 | 20.05 | 21.09 |
Operating CF per Share |
0.00 | 2.50 | 2.34 | 1.88 | 1.68 | 2.74 | 2.48 | 2.82 | 4.20 | 4.60 |
Capex per Share |
0.00 | 0.00 | (1.46) | (1.38) | (1.15) | (2.41) | (1.52) | (1.73) | (1.36) | (1.33) |
Free Cash Flow per Share |
0.00 | 2.50 | 0.88 | 0.50 | 0.54 | 0.34 | 0.96 | 1.09 | 2.85 | 3.27 |
Cash per Share |
0.00 | 0.35 | 0.47 | 1.68 | 3.18 | 3.21 | 1.99 | 2.22 | 3.70 | 3.26 |
Shareholders Equity per Share |
0.00 | 46.83 | 46.37 | 39.54 | 38.49 | 39.30 | 40.04 | 41.83 | 43.59 | 44.68 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 46.83 | 46.37 | 39.54 | 38.49 | 39.30 | 40.04 | 41.83 | 43.59 | 44.68 |
Free Cash Flow |
1,202.94 | 1,223.47 | 428.00 | 244.00 | 262.00 | 165.00 | 472.00 | 537.00 | 1,407.00 | 1,613.00 |
Working Capital |
1,349.02 | 1,500.00 | 1,506.00 | 1,936.00 | 2,729.00 | 2,914.00 | 2,455.00 | 3,249.00 | 4,031.00 | 3,400.00 |
Capital Expenditures |
(521.57) | (614.29) | (712.00) | (676.00) | (561.00) | (1,180.00) | (745.00) | (851.00) | (670.00) | (658.00) |
Net Current Asset Value |
(1,702.94) | (1,066.33) | (1,024.00) | (4,116.00) | (3,791.00) | (3,357.00) | (4,295.00) | (3,343.00) | (2,485.00) | (3,071.00) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 77.92 | 55.90 | 40.06 | 31.69 | 30.88 |
Capex to Sales |
0.00 | 0.00 | 0.10 | 0.09 | 0.08 | 0.14 | 0.09 | 0.09 | 0.07 | 0.06 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 73.60 | 50.44 | 36.56 | 29.70 | 28.58 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.55 | 0.51 | 0.58 | 0.47 | 0.47 | 0.33 | 0.28 | 0.28 | 0.28 | 0.25 |
Cash ROIC |
5.15% | 5.27% | 1.86% | 1.03% | 1.07% | 0.66% | 1.87% | 2.03% | 5.02% | 5.68% |
Accounts Receivable Turnover |
4.05 | 4.33 | 4.83 | 5.53 | 4.90 | 5.74 | 5.46 | 5.42 | 5.56 | 5.59 |
Accounts Payable Turnover |
5.29 | 5.66 | 5.95 | 5.14 | 4.56 | 4.09 | 4.50 | 5.03 | 5.55 | 5.48 |
Inventory Turnover |
2.69 | 2.88 | 2.90 | 2.61 | 2.47 | 2.05 | 1.98 | 1.90 | 1.92 | 2.00 |
Average Days of Payables |
65.60 | 67.69 | 61.09 | 79.05 | 82.13 | 90.57 | 79.18 | 70.35 | 64.14 | 72.59 |
Days of Inventory on Hand |
130.46 | 131.24 | 132.69 | 142.83 | 154.14 | 190.47 | 193.95 | 201.41 | 188.18 | 187.44 |
Average Receivables |
1,574.61 | 1,574.61 | 1,480.55 | 1,356.50 | 1,394.50 | 1,443.50 | 1,595.50 | 1,745.00 | 1,781.50 | 1,860.50 |
Average Payables |
636.63 | 636.63 | 665.68 | 748.00 | 854.50 | 889.50 | 882.00 | 836.00 | 792.00 | 849.50 |
Average Inventory |
1,249.43 | 1,249.43 | 1,367.96 | 1,472.50 | 1,574.50 | 1,771.50 | 2,004.00 | 2,215.50 | 2,295.00 | 2,329.50 |
Average Assets |
27,437.94 | 13,820.59 | 27,351.59 | 27,358.50 | 27,627.50 | 27,799.50 | 28,582.00 | 29,389.50 | 29,980.50 | 30,951.00 |
Average Common Equity |
22,914.71 | 22,914.71 | 22,769.50 | 20,971.00 | 19,062.50 | 19,039.00 | 19,466.50 | 20,150.50 | 21,088.50 | 21,794.00 |
Columns are period end dates